Supporting Takahashi Keisei’s Raku-Ryu Series Expansion in the U.S.: Making Specimen Collection Easier for Patients and Providers
We are excited to support Takahashi Keisei’s healthcare innovation, the Raku-Ryu series, as it expands in the United States. Specimen-based testing continues to grow across both at-home diagnostics and clinical settings, including FIT colorectal cancer screening, gut microbiome research, and ca...


